Clinical study on patients of Insomnia

Therapeutic evaluation of Neuropharmacological effects of Roghan-e-Banafsha Nasal drops in the patients of Insomnia: An exploratory/ pilot Clinical study - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084716

Enrollment

Registered

2025-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: Qutur (Nasal Drops) with Unani Medicine for 28 days: Therapeutic Evaluation of Neuropharmacological Effects of Roghan-e-Banafsha (Viola odorata) Nasal Drops in patients of Insomnia. Con

Eligibility

Inclusion criteria

Inclusion criteria: Adults students and patients (OPD & IPD) aged 18-60 years with a diagnosis of insomnia. Patients of all genders. Patients who are willing to sign the informed consent form and participate in the trail voluntarily.

Exclusion criteria

Exclusion criteria: Patients with history of severe psychiatric or neurological conditions. Patients used sedative-hypnotic drugs in the last 4 weeks.

Design outcomes

Primary

Measure	Time frame
Severity of insomnia will be assessed using Insomnia Severity Index (ISI)Timepoint: 1st day, 28th day	—

Secondary

Measure	Time frame
Mizaj (Temperament Assessment) will be assessed using Mizaj Assessment Tool developed by CCRUMTimepoint: Baseline	—

Countries

India

Contacts

Public ContactDr Zehra Zaidi

Jamia Hamdard

syedafzalhussain35@gmail.com8376996940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026